Stockreport

Protagenic Therapeutics Announces Resolution of Nasdaq Deficiency Notice [Yahoo! Finance]

Protagenic Therapeutics, Inc.  (PTIX) 
US:NASDAQ Investor Relations: protagenic.com/investors
PDF Nasdaq Listing Rule 5550(a)(2) as the closing bid price of shares of PTIX has remained above $1.00 per share for ten consecutive trading days. This resolves the issue of [Read more]